Summary:

- This article discusses the potential for medical marijuana research to lead to the reclassification of cannabis under federal law. Currently, cannabis is classified as a Schedule I drug, which means it is considered to have a high potential for abuse and no accepted medical use.

- However, as more research is conducted on the potential medical benefits of cannabis, there is growing pressure to reclassify it to a lower schedule, which would make it easier for researchers to study and potentially lead to the development of new medical treatments.

- The article highlights the challenges that researchers have faced in studying cannabis due to its current classification, and the potential implications of reclassification for the development of new cannabis-based medications and therapies.